Statement from the ESC regarding the ongoing CT-scan vs. invasive angiography debate

December 03, 2008

Recent media reports based on a new study published in the New England Journal of Medicine (27 November 2008 issue) have announced that "noninvasive CT scans cannot replace imaging of coronary artery blockages by conventional invasive angiography".

In response, imaging specialist Professor Juhani Knuuti, spokesperson for the European Society of Cardiology and Past-Chair of the ESC Working Group on Nuclear Cardiology and Cardiac CT, emphasizes the following points.

The CT imaging techniques have developed very rapidly and during recent years the use of CT to image coronary arteries has been rapidly growing. While it was initially hoped that this noninvasive test could even replace invasive coronary angiography, it has been obvious for couple of years that this is not the case.

The strength of invasive coronary angiography is that the treatment procedures such as dilation of stenosis and stenting can be done in the same session, which is never the case with noninvasive imaging studies. However, due to risks of invasive procedures, these tests should be ideally limited to the patients with high likelihood of disease and necessary procedures.

The strength of CT angiography in the previous studies was the very high negative predictive value i.e. when the result of test is negative the significant coronary artery disease is very unlikely. Consequently, ESC imaging experts have recommended CT angiography to be at the best in excluding coronary artery disease in the patients with low to moderate pre-test likelihood of disease (Eur Heart J. 2008; 29(4):531-56).

The debated study by JM Miller and colleagues (N Engl J Med. 2008; 359(22):2324-2336) is the first multicentre trial for 64-slice CT angiography. While the results were mainly in agreement with the previous single centre studies and demonstrated good accuracy in general, the negative predictive value was somewhat lower (83%). This raises questions whether the technique is indeed very precise in excluding coronary artery stenoses when applied in clinical routine and in multiple sites.

Another issue that was actively discussed, was the radiation risks of the CT scans. It is obvious that all necessary actions are needed to minimize the risks of imaging, including radiation risks. In the debated study, the radiation doses by CT were 2-3 fold higher than in invasive angiography, but still in moderate level. However, with the current generation of CT scanners, which were not widely available at the time the study was started, the radiation dose is ranging from 3 to 7 mSv, which is actually less than with invasive angiography. Newer techniques are looking at lowering the radiation dose even further.

While waiting further studies and confirmation of these results, it is important to emphasize one completely ignored issue in the current debate. The fact is that anatomical imaging, noninvasive or invasive, does not accurately tell whether the detected coronary blockages are causing ischemia and whether the lesions are the cause of the symptoms of the patients. As it is stated clearly also by clinical guidelines, functional ischemia testing is needed to assess whether the coronary stenoses are hemodynamically significant i.e. how much blockage prevents the blood from flowing. This can be done by cardiac nuclear imaging, stress echocardiography, magnetic resonance imaging or invasive flow measurements. Using CT, now also noninvasive imaging of coronary anatomy is possible and it is very likely that this information will be combined with functional imaging findings making finally comprehensive noninvasive evaluation possible.

European Society of Cardiology

Related Radiation Dose Articles from Brightsurf:

Observation vs. targeted high-dose radiation for metastatic prostate cancer
This randomized clinical trial compared how effectively high-dose, targeted radiation therapy versus no treatment (observation) among 54 men prevented the progression over six months of recurrent hormone-sensitive prostate cancer that has metastasized to a small number of sites in the body.

Trial finds high-dose radiation effective for men whose prostate cancer has spread
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy.

Immune damage may explain ineffectiveness of high-dose radiation against lung cancer
study finds 14.3 month vs. 28.2 month median survival for high- vs. low-dose radiation in patients with stage III non-small cell lung cancer.

CNIO researchers discover a new way to protect against high-dose radiation damage
Intensive radiotherapy can be toxic in 60% of patients with tumors located in the gastrointestinal cavity.

Low-dose radiation therapy improves delivery of therapeutic nanoparticles to brain tumors
A new study led by Massachusetts General Hospital investigators finds that radiation therapy may increase the uptake of therapeutic nanoparticles by glioblastomas, raising the possibility of using both growth-factor-targeted and immune-system-based therapies against the deadly brain tumor.

Higher radiation dose needed to X-ray obese patients increases cancer risk
Extremely obese people are needing a far higher dose of radiation during x-ray examinations than people of normal weight, increasing their risk of cancer, new research has shown.

High-dose radiation therapy improves survival in patients once thought incurable
In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggressive form of high-precision radiation therapy can greatly increase how long oligometastatic patients live and doubles how long they live without cancer.

New material detects the amount of UV radiation and helps monitor radiation dose
Researchers at the University of Turku, Finland, have developed a synthetic SensoGlow™ material that detects the quantity and quality of ultraviolet radiation from the Sun or other sources.

Scientists calculate radiation dose in bone from victim of Hiroshima bombing
In an article published in PLOS ONE, Brazilian researchers describe the first retrospective dosimetric study by electron spin resonance spectroscopy using human tissue from nuclear attack victims.

Large nuclear cardiology laboratory slashes radiation dose by 60 percent in 8 years
A large nuclear cardiology laboratory has slashed its average radiation dose by 60 percent in eight years, according to new research presented today at ICNC 2017 and published in JACC: Cardiovascular Imaging.

Read More: Radiation Dose News and Radiation Dose Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to